Abstract:The co-existence of coronavirus disease 2019 (COVID-19) and seasonal influenza epidemics has become a potential threat to human health, particularly in China in the oncoming season. However, with the relaxation of nonpharmaceutical interventions (NPIs) during the COVID-19 pandemic, the rebound extent of the influenza activities is still poorly understood. In this study, we constructed a susceptible-vaccinated-infectious-recovered-susceptible (SVIRS) model to simulate influenza transmission and calibrated it using influenza surveillance data from 2018 to 2022. We projected the influenza transmission over the next 3 years using the SVIRS model. We observed that, in epidemiological year 2021–2022, the reproduction numbers of influenza in southern and northern China were reduced by 64.0% and 34.5%, respectively, compared with those before the pandemic. The percentage of people susceptible to influenza virus increased by 138.6% and 57.3% in southern and northern China by October 1, 2022, respectively. After relaxing NPIs, the potential accumulation of susceptibility to influenza infection may lead to a large-scale influenza outbreak in the year 2022-2023, the scale of which may be affected by the intensity of the NPIs. And later relaxation of NPIs in the year 2023 would not lead to much larger rebound of influenza activities in the year 2023-2024. To control the influenza epidemic to the pre-pandemic level after relaxing NPIs, the influenza vaccination rates in southern and northern China should increase to 53.8% and 33.8%, respectively. Vaccination for influenza should be advocated to reduce the potential reemergence of the influenza epidemic in the next few years.### Competing Interest StatementThe authors have declared no competing interest.### Funding StatementThis study was funded by grants from the National Natural Science Foundation of China (Grant No. 82003509, 82173577, 81672005), and the Natural Science Foundation of Zhejiang Province (Grant No. LQ20H260009).### Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors

Prediction of Upcoming Global Infection Burden of Influenza Seasons after Relaxation of Public Health and Social Measures During the COVID-19 Pandemic: a Modelling Study

Forecasting of influenza activity and associated hospital admission burden and estimating the impact of COVID-19 pandemic on 2019/20 winter season in Hong Kong

Modeling the Impact of Mass Influenza Vaccination and Public Health Interventions on COVID-19 Epidemics with Limited Detection Capability.

Increased population susceptibility to seasonal influenza during the COVID‐19 pandemic in China and the United States

Impact of early phase COVID-19 precautionary behaviors on seasonal influenza in Hong Kong: A time-series modeling approach

Predicting influenza in China from October 1, 2023, to February 5, 2024: A transmission dynamics model based on population migration

Mitigating co-circulation of seasonal influenza and COVID-19 pandemic in the presence of vaccination: A mathematical modeling approach

The Incoming Influenza Season — China, the United Kingdom, and the United States, 2021–2022

COVID-19 and the flu: data simulations and computational modelling to guide public health strategies

A seesaw effect between COVID-19 and influenza during 2020-2023 in WHO regions.

Quantifying the Rebound of Influenza Epidemics after Relaxing Nonpharmaceutical Interventions During the Coronavirus Disease 2019 Pandemic in China

Shifts in Seasonal Influenza Patterns in Australia During and After COVID-19: A Comprehensive Analysis

Modelling the impact of universal influenza vaccines on seasonal influenza with different subtypes.

From Outbreak to Near Disappearance: How Did Non-pharmaceutical Interventions Against COVID-19 Affect the Transmission of Influenza Virus?

Influenza and COVID-19 co-infection and vaccine effectiveness against severe cases: a mathematical modeling study

Influenza’s plummeting and future dynamics: the roles of mask wearing, mobility change and SARS-CoV-2 interference

The Effects of Mask Wearing, Mobility Change and SARS-CoV-2 Interference on Seasonal Influenza in Northern China, Southern China, England, and the United States

Combinational Recommendation of Vaccinations, Mask-Wearing, and Home-Quarantine to Control Influenza in Megacities: An Agent-Based Modeling Study With Large-Scale Trajectory Data

Changes in the Epidemiological Features of Influenza After the COVID-19 Pandemic in China, the United States, and Australia: Updated Surveillance Data for Influenza Activity

Global variability of influenza activity and virus subtype circulation from 2011 to 2023